Association of 5 Well-Defined Polymorphisms in the Gene Encoding Transforming Growth Factor-β1 with Coronary Artery Disease among Chinese Patients with Hypertension

Angiology

Volumn 66, Issue 7, 2015, Pages 652-658

  Xu, Junxia ^a   Yu, Xiaohong ^b   Huang, Changfu ^c   Qin, Ruiqiang ^d   Peng, Feng ^a   Lin, Jinxiu ^a   Niu, Wenquan ^e,f,g  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b DALIAN MEDICAL UNIVERSITY   (China)

^c Armament Department of Fujian Provincial military command   (China)

^d Forth Sanatorium of Fujian Provincial Military Region   (China)

^e SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^f Shanghai Institute of Hypertension   (China)

^g NONE   (China)

Author keywords

coronary artery disease; epistasis; genetic polymorphism; haplotype; transforming growth factor 1

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HIGH SENSITIVITY C REACTIVE PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ANGIOGRAPHY; ARTICLE; BODY MASS; CASE CONTROL STUDY; CHINESE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIASTOLIC BLOOD PRESSURE; DNA POLYMORPHISM; EPISTASIS; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; GLUCOSE BLOOD LEVEL; HAPLOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; AGED; ALLELE; ANGIOCARDIOGRAPHY; BLOOD; CHINA; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PHENOTYPE; RADIOGRAPHY; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ALLELES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHINA; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSFORMING GROWTH FACTOR BETA;

EID: 84937947364     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319714547946     Document Type: Article

References (28)

1. Vargas JD, Lima JA,. Coronary artery disease: a gene-expression score to predict obstructive CAD. Nat Rev Cardiol. 2013; 10 (5): 243-244.
2. Del Monte G, Harvey RP,. An endothelial contribution to coronary vessels. Cell. 2012; 151 (5): 932-934.
3. Swerdlow DI, Holmes MV, Harrison S, Humphries SE,. The genetics of coronary heart disease. Br Med Bulletin. 2012; 102: 59-77.
4. Pan Q, Hu T, Moore JH,. Epistasis, complexity, and multifactor dimensionality reduction. Methods Mol Biol. 2013; 1019: 465-477.
5. Jin W, Su X, Xu M,. Interactive association of five candidate polymorphisms in apelin/APJ pathway with coronary artery disease among Chinese hypertensive patients. PLoS One. 2012; 7 (12): e51123.
6. Grainger DJ,. TGF-beta and atherosclerosis in man. Cardiovasc Res. 2007; 74 (2): 213-222.
7. Sie MP, Uitterlinden AG, Bos MJ,. TGF-beta 1 polymorphisms and risk of myocardial infarction and stroke: the Rotterdam study. Stroke. 2006; 37 (11): 2667-2671.
8. Martin-Garrido A, Williams HC, Lee M,. Transforming growth factor beta inhibits platelet derived growth factor-induced vascular smooth muscle cell proliferation via Akt-independent, Smad-mediated cyclin D1 downregulation. PLoS One. 2013; 8 (11): e79657.
9. Suwanabol PA, Seedial SM, Shi X,. Transforming growth factor-beta increases vascular smooth muscle cell proliferation through the Smad3 and extracellular signal-regulated kinase mitogen-activated protein kinases pathways. J Vasc Surg. 2012; 56 (2): 446-454.
10. Koch W, Hoppmann P, Mueller JC, Schomig A, Kastrati A,. Association of transforming growth factor-beta1 gene polymorphisms with myocardial infarction in patients with angiographically proven coronary heart disease. Arterioscler Thromb Vasc Biol. 2006; 26 (5): 1114-1119.
11. DiChiara MR, Kiely JM, Gimbrone MA Jr, Lee ME, Perrella MA, Topper JN,. Inhibition of E-selectin gene expression by transforming growth factor beta in endothelial cells involves coactivator integration of Smad and nuclear factor kappaB-mediated signals. J Exp Med. 2000; 192 (5): 695-704.
12. Bogavac-Stanojevic N, Djurovic S, Jelic-Ivanovic Z, Spasojevic-Kalimanovska V, Kalimanovska-Ostric D,. Circulating transforming growth factor-beta1, lipoprotein(a) and cellular adhesion molecules in angiographically assessed coronary artery disease. Clin Chem Lab Med. 2003; 41 (7): 893-898.
13. Morris DR, Moxon JV, Biros E, Krishna SM, Golledge J,. Meta-analysis of the association between transforming growth factor-beta polymorphisms and complications of coronary heart disease. PLoS One. 2012; 7 (5): e37878.
14. Yu X, Liu J, Zhu H,. Synergistic association of DNA repair relevant gene polymorphisms with the risk of coronary artery disease in northeastern Han Chinese. Thromb Res. 2014; 133 (2): 229-234.
15. Yu X, Liu J, Zhu H,. An interactive association of advanced glycation end-product receptor gene four common polymorphisms with coronary artery disease in northeastern Han Chinese. PLoS One. 2013; 8 (10): e76966.
16. Khanna M, Park P, Zirvi M,. Multiplex PCR/LDR for detection of K-ras mutations in primary colon tumors. Oncogene. 1999; 18 (1): 27-38.
17. Stram DO, Leigh Pearce C, Bretsky P,. Modeling and E-M estimation of haplotype-specific relative risks from genotype data for a case-control study of unrelated individuals. Hum Hered. 2003; 55 (4): 179-190.
18. Pattin KA, White BC, Barney N,. A computationally efficient hypothesis testing method for epistasis analysis using multifactor dimensionality reduction. Genet Epidemiol. 2009; 33 (1): 87-94.
19. Hahn LW, Ritchie MD, Moore JH,. Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics. 2003; 19 (3): 376-382.
20. Wu X, Gu J, Grossman HB,. Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. Am J Hum Genet. 2006; 78 (3): 464-479.
21. Niu W, Qi Y, Hou S, Zhai X, Zhou W, Qiu C,. Haplotype-based association of the renin-angiotensin-aldosterone system genes polymorphisms with essential hypertension among Han Chinese: the Fangshan study. J Hypertens. 2009; 27 (7): 1384-1391.
22. Niu W, Wu S, Zhang Y,. Validation of genetic association in apelin-AGTRL1 system with hypertension in a larger Han Chinese population. J Hypertens. 2010; 28 (9): 1854-1861.
23. Qi Y, Niu W, Zhu T, Zhou W, Qiu C,. Synergistic effect of the genetic polymorphisms of the renin-angiotensin-aldosterone system on high-altitude pulmonary edema: a study from Qinghai-Tibet altitude. Eur J Epidemiol. 2008; 23 (2): 143-152.
24. Ritchie MD, Hahn LW, Roodi N,. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet. 2001; 69 (1): 138-147.
25. Niu W, Qi Y,. Matrix metalloproteinase family gene polymorphisms and risk for coronary artery disease: systematic review and meta-analysis. Heart. 2012; 98 (20): 1483-1491.
26. Moore JH, Ritchie MD,. STUDENT JAMA. The challenges of whole-genome approaches to common diseases. JAMA. 2004; 291 (13): 1642-1643.
27. Gui J, Andrew AS, Andrews P,. A simple and computationally efficient sampling approach to covariate adjustment for multifactor dimensionality reduction analysis of epistasis. Hum Hered. 2010; 70 (3): 219-225.
28. Zintzaras E, Raman G, Kitsios G, Lau J,. Angiotensin-converting enzyme insertion/deletion gene polymorphic variant as a marker of coronary artery disease: a meta-analysis. Arch Intern Med. 2008; 168 (10): 1077-1089.